Clinical Trial Update: A Phase 1 Safety Study of SANGUINATE™ In Patients With Acute Severe Anemia. [Phase 1]

View source ↗

Summary

This Clinical Trial Update reports the completion of a Phase 1 safety study of SANGUINATE in patients with acute severe anemia. The sponsor is Prolong Pharmaceu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anemia

Drugs mentioned

• SANGUINATE

Snippet

Sponsor: Prolong Pharmaceuticals | Conditions: Acute Anemia | Phase 1 | Status: COMPLETED